Novel pathogenic COX20 variants causing dysarthria, ataxia, and sensory neuropathy.

Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension.

Programmable RNA targeting with the single-protein CRISPR effector Cas7-11.